QualityStocksNewsBreaks – VERAXA Biotech AG Secures $27.5 Million Senior Secured Financing and $50 Million Equity Line Ahead of Planned Nasdaq Listing ibn.fm/oxUOU#stocks#stockmarket#biotech
$RDGL - Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy(TM) ibn.fm/TYrZ0#stocks